Found: 93
Select item for more details and to access through your institution.
Long-term complete remission with belinostat in a patient with chemotherapy refractory peripheral t-cell lymphoma.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-69
- By:
- Publication type:
- Article
Azacitidine in patients with WHO-defined AML - Results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-32
- By:
- Publication type:
- Article
Inhibition of protein kinase CK2 with the clinicalgrade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-78
- By:
- Publication type:
- Article
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-88
- By:
- Publication type:
- Article
miR-363-5p regulates endothelial cell properties and their communication with hematopoietic precursor cells.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-87
- By:
- Publication type:
- Article
Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma study group.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-86
- By:
- Publication type:
- Article
FISH<sup>+</sup>CD34<sup>+</sup>CD38<sup>-</sup> cells detected in newly diagnosed acute myeloid leukemia patients can predict the clinical outcome.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-85
- By:
- Publication type:
- Article
Enhancing bone marrow regeneration by SALL4 protein.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-84
- By:
- Publication type:
- Article
Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical application.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 3, doi. 10.1186/1756-8722-6-83
- By:
- Publication type:
- Article
STAT3 mutations are frequent in T-cell large granular lymphocytic leukemia with pure red cell aplasia.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-82
- By:
- Publication type:
- Article
Interim analysis of safety and efficacy of ruxolitinib in patients with myelofibrosis and low platelet counts.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 3, doi. 10.1186/1756-8722-6-81
- By:
- Publication type:
- Article
Adjuvant zoledronic acid therapy for patients with early stage breast cancer: an updated systematic review and meta-analysis.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-80
- By:
- Publication type:
- Article
Optimizing management of ruxolitinib in patients with myelofibrosis: the need for individualized dosing.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-79
- By:
- Publication type:
- Article
A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-17
- By:
- Publication type:
- Article
Clinical significance of cytogenetic aberrations in bone marrow of patients with diffuse large B-cell lymphoma: prognostic significance and relevance to histologic involvement.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-76
- By:
- Publication type:
- Article
Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-77
- By:
- Publication type:
- Article
IGF binding protein 2 is a cell-autonomous factor supporting survival and migration of acute leukemia cells.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-72
- By:
- Publication type:
- Article
G-CSF/anti-G-CSF antibody complexes drive the potent recovery and expansion of CD11b<sup>+</sup>Gr-1<sup>+</sup> myeloid cells without ompromising CD8<sup>+</sup> T cell immune responses.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-75
- By:
- Publication type:
- Article
Stem cell factor SALL4, a potential prognostic marker for myelodysplastic syndromes.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-73
- By:
- Publication type:
- Article
Differential responses to genotoxic agents between induced pluripotent stem cells and tumor cell lines.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-71
- By:
- Publication type:
- Article
Population level survival of patients with chronic myelocytic leukemia in Germany compared to the US in the early 21st century.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-70
- By:
- Publication type:
- Article
Leukemic transformation driven by an ASXL1 mutation after a JAK2V617F-positive primary myelofibrosis: clonal evolution and hierarchy revealed by next-generation sequencing.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-68
- By:
- Publication type:
- Article
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-67
- By:
- Publication type:
- Article
Perioperative therapy for locally advanced gastroesophageal cancer: current controversies and consensus of care.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-66
- By:
- Publication type:
- Article
Erythropoietin is a JAK2 and ERK1/2 effector that can promote renal tumor cell proliferation under hypoxic conditions.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-65
- By:
- Publication type:
- Article
Proliferation inhibition and apoptosis induction of imatinib-resistant chronic myeloid leukemia cells via PPP2R5C down-regulation.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-64
- By:
- Publication type:
- Article
The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-74
- By:
- Publication type:
- Article
High rate of spontaneous inhibitor clearance during the long term observation study of a single cohort of 524 haemophilia A patients not undergoing immunotolerance.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-63
- By:
- Publication type:
- Article
Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-62
- By:
- Publication type:
- Article
An evolving new paradigm: endothelial cells - conditional innate immune cells.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-61
- By:
- Publication type:
- Article
PAX8: a sensitive and specific marker to identify cancer cells of ovarian origin for patients prior to neoadjuvant chemotherapy.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-60
- By:
- Publication type:
- Article
Ibrutinib and novel BTK inhibitors in clinical development.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-59
- By:
- Publication type:
- Article
Enhanced levels of asymmetric dimethylarginine in a serum of middle age patients with myelodysplastic syndrome.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-58
- By:
- Publication type:
- Article
Epigenetic changes: a common theme in acute myelogenous leukemogenesis.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-57
- By:
- Publication type:
- Article
Immunoglobulin E induces VEGF production in mast cells and potentiates their pro-tumorigenic actions through a Fyn kinase-dependent mechanism.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-56
- By:
- Publication type:
- Article
Immunomodulation therapy with lenalidomide in follicular, transformed and diffuse large B cell lymphoma: current data on safety and efficacy.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-55
- By:
- Publication type:
- Article
Biomarkers for determining the prognosis in chronic myelogenous leukemia.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-54
- By:
- Publication type:
- Article
Inosine Triphosphate Pyrophosphohydrolase (ITPA) polymorphic sequence variants in adult hematological malignancy patients and possible association with mitochondrial DNA defects.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-24
- By:
- Publication type:
- Article
Histone deacetylase inhibitor potentiated the ability of MTOR inhibitor to induce autophagic cell death in Burkitt leukemia/lymphoma.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-53
- By:
- Publication type:
- Article
Protein biomarkers distinguish between high- and low-risk pediatric acute lymphoblastic leukemia in a tissue specific manner.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-52
- By:
- Publication type:
- Article
Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-51
- By:
- Publication type:
- Article
Signal transduction inhibitors in treatment of myelodysplastic syndromes.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-50
- By:
- Publication type:
- Article
Induction of acquired drug resistance in endothelial cells and its involvement in anticancer therapy.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-49
- By:
- Publication type:
- Article
A phase I study of ridaforolimus in adult Chinese patients with advanced solid tumors.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-48
- By:
- Publication type:
- Article
Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-47
- By:
- Publication type:
- Article
A phase II study of sorafenib (BAY 43-9006) in recurrent diffuse large B cell lymphoma: an eastern cooperative oncology group study (E1404).
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-46
- By:
- Publication type:
- Article
Early stage follicular lymphoma: what is the clinical impact of the first-line treatment strategy?
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-45
- By:
- Publication type:
- Article
A prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal type.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-44
- By:
- Publication type:
- Article
L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancer.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-43
- By:
- Publication type:
- Article
A multicenter, open-label, phase 2 study of lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: the MM-021 trial.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-41
- By:
- Publication type:
- Article